Plain-English translation of NCT07312526 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term registry study that follows patients who have undergone surgery to remove esophageal cancer. Researchers will collect and monitor health information from about 3,500 patients across hospitals in Shanghai to better understand how people recover and do after cancer surgery, and to identify ways to improve treatment outcomes.
By tracking many patients over time, researchers can learn which factors affect survival and quality of life after esophageal cancer surgery, and use these insights to develop better care plans and treatments for future patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, your doctors and the research team will regularly collect information about your health, recovery, and any symptoms or side effects you experience after your surgery. This typically involves follow-up visits at your hospital and sharing your medical records—there are no new medications or procedures required just for the study. The research team will keep track of your progress over an extended period to understand your long-term outcomes.
AI-generated summary from trial data · Nov 17, 2026 · Not medical advice
China
Collaborators
Shanghai Zhongshan Hospital, Shanghai Cancer Hospital, China
Enrollment target
~3,500 participants
Started
July 2025
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Last updated on clinicaltrials.gov in November 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Zhigang Li, Prof.
Shanghai Chest Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.